[SGYP] Synergy Pharmaceuticals, Inc.
Overview
Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization:
Exchange: NASDAQ
The data is delayed by 15 minutes.
Strongest Trends Summary For SGYP
SGYP is in the medium-term down -100% in 1 year. In the long-term down -100% below S&P in 3 years.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders, as well as is in Phase IIb clinical trials for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company also develops SP-333, which is in Phase II clinical trials to treat GI inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
Fundamental Ratios
| Shares Outstanding | EPS | EPS Growth - 4 Quarters | EPS Growth - Q/Q | ||||
| EPS Growth - Y/Y | Sales Growth - 4 Quarters | Sales Growth - Q/Q | P/E | ||||
| P/E To EPS Growth | P/S | P/BV | Price/Cash Per Share | ||||
| Price/Free Cash Flow | ROA | -54.85% | ROE | 432.02% | ROI | ||
| Current Ratio | 9.53 | Quick Ratio | Long Term Debt/Equity | 1.23 | Debt Ratio | -0.77 | |
| Gross Margin | Operating Margin | Net Profit Margin | Dividend Payout Ratio | ||||
| Dividend Yield |
Fundamental Data
| Cash From Financing Activities | 5.41 M | Cash From Investing Activities | -50.01 M | Cash From Operating Activities | -23.15 M | Gross Profit | |
| Net Profit | -27.39 M | Operating Profit | -22.8 M | Total Assets | 194.83 M | Total Current Assets | 182.28 M |
| Total Current Liabilities | 19.13 M | Total Debt | 200 M | Total Liabilities | 219.57 M | Total Revenue |
Technical Data
| High 52 week | 2.23 | Low 52 week | 0.07 | Last close | 0.24 | Last change | -17.21% |
| RSI | 42.37 | Average true range | 0.03 | Beta | 0.79 | Volume | 31.45 M |
| Simple moving average 20 days | -22.7% | Simple moving average 50 days | -1.08% | Simple moving average 200 days | -79.06% |
Performance Data
| Performance Week | -22.62% | Performance Month | -36.75% | Performance Quart | -37.23% | Performance Half | -87.69% |
| Performance Year | -87.09% | Performance Year-to-date | 110.8% | Volatility daily | 9.36% | Volatility weekly | 20.93% |
| Volatility monthly | 42.89% | Volatility yearly | 148.57% | Relative Volume | 577.63% | Average Volume | 13.41 M |
| New High | New Low |
News
2019-04-12 15:00:00 | FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC - UXIN, SGYP & MHLD
2019-04-12 10:19:00 | FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC - UXIN, SGYP & MHLD
2019-04-11 16:45:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-04-09 20:06:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-04-09 10:24:00 | SGYP & MHLD - Class Action Bronstein, Gewirtz & Grossman, LLC
2019-04-07 09:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
2019-04-05 10:23:00 | Class Action Bronstein, Gewirtz & Grossman, LLC - SGYP & MHLD
2019-04-04 15:10:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-04-03 10:22:00 | Class Action Reminder Bronstein, Gewirtz & Grossman, LLC - SGYP & MHLD
2019-04-02 15:35:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-03-29 15:00:00 | Bronstein, Gewirtz & Grossman, LLC Class Action Update - UXIN, SGYP & MHLD
2019-03-29 10:57:00 | Bronstein, Gewirtz & Grossman, LLC Class Action Reminder - UXIN, SGYP & MHLD
2019-03-28 14:27:31 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
2019-03-28 10:57:00 | Bronstein, Gewirtz & Grossman, LLC Class Action Update - UXIN, SGYP & MHLD
2019-03-26 16:15:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-03-21 15:00:00 | INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceuticals, Inc. SGYP and Lead Deadline: April 12, 2019
2019-03-21 10:08:00 | INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Deadline: April 12, 2019
2019-03-19 19:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
2019-03-19 11:08:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Deadline: April 12, 2019
2019-03-15 10:02:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Deadline: April 12, 2019
2019-03-14 21:14:50 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
2019-03-12 16:57:33 | [$$] Synergy Pharma Bankruptcy Plan Cleared for Creditor Poll
2019-03-11 15:00:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Plaintiff Deadline: April 12, 2019
2019-03-11 10:01:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Plaintiff Deadline: April 12, 2019
2019-03-07 20:47:59 | Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in Synergy Pharmaceuticals, Inc. – SGYP
2019-03-06 09:00:00 | Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.
2019-03-05 08:04:11 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2019-03-04 14:12:13 | Chester County to lose 137 pharma jobs
2019-03-01 18:30:00 | Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
2019-02-28 16:24:43 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
2019-02-27 08:13:48 | The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings
2019-02-26 18:04:00 | Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
2019-02-26 18:00:00 | Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets
2019-02-26 17:25:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
2019-02-25 12:35:45 | [$$] Puerto Rico's Debt Saga May Land Back in Washington's Lap
2019-02-22 17:48:17 | [$$] Synergy Pharmaceuticals Wins Approval for Bankruptcy Loan
2019-02-20 18:15:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
2019-02-20 17:11:00 | Investor Alert: Kaplan Fox Announces Investigation Of Synergy Pharmaceuticals Inc.
2019-02-20 17:08:49 | Bausch Health Companies Inc BHC Q4 2018 Earnings Conference Call Transcript
2019-02-13 15:22:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
2019-02-13 11:41:57 | [$$] Firm Retention Summary: Synergy Pharmaceuticals Inc.
2019-02-12 11:28:45 | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Synergy Pharmaceuticals Inc. SGYP
2019-01-29 08:04:59 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2019-01-25 08:00:00 | Small Cap Stocks Breaking Out